MedTrace Logo

Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

NCT02024971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1103

Last updated 2016-11-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the safety and efficacy of long-term use of pioglitazone/metformin hydrochloride combination tablets in the routine clinical setting in patients with type 2 diabetes mellitus for whom therapy with pioglitazone hydrochloride combined with metformin hydrochloride is considered suitable.

Conditions

Interventions

DRUG

Pioglitazone/metformin hydrochloride

Pioglitazone/metformin hydrochloride combination tablets

Sponsors & Collaborators

Principal Investigators

  • Postmarketing Group Manager · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2013-11-30
Completion
2013-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02024971 on ClinicalTrials.gov